プロモーションスケジュール INVO Bioscience, Inc.
詳細なスケジュール
簡易グラフ
会社について INVO Bioscience, Inc.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.IPO date | 2012-05-21 |
---|---|
ISIN | US44984F3029 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.invobio.com |
Цена ао | 0.722 |
1日あたりの価格変動: | +0% (0.722) |
---|---|
週ごとの価格変動: | +0% (0.722) |
月ごとの料金変更: | +0% (0.722) |
3ヶ月間の価格変動: | -11.95% (0.82) |
半年間の価格変動: | +3.88% (0.695) |
年間の価格変動: | -29.9% (1.03) |
3年間の価格推移: | -68.74% (2.31) |
5年間の価格推移: | +178.12% (0.2596) |
年初からの価格変動: | -9.75% (0.8) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
機関 | 音量 | 共有, % |
---|---|---|
Vanguard Group Inc | 54058 | 2.18 |
Geode Capital Management, LLC | 26826 | 1.08 |
Sabby Management, LLC | 18624 | 0.75 |
UBS Group AG | 7155 | 0.29 |
Tower Research Capital LLC (TRC) | 4945 | 0.2 |
Osaic Holdings Inc | 559 | 0.02 |
Royal Bank of Canada | 538 | 0.02 |
Aspire Private Capital, LLC | 115 | 0 |
Morgan Stanley | 37 | 0 |
Blackrock Inc. | 24 | 0 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Mr. Steven M. Shum | CEO & Director | 201.88k | 1971 (54 年) |
Mr. Andrea Goren | Chief Financial Officer | 173.75k | 1967 (58 年) |
Mr. Michael Jos. Campbell | COO & VP of Business Development | 220k | 1958 (67 年) |
Mr. Bojan Mitrovic Ph.D. | Director of Sales US | N/A | |
Mr. Robert Joseph Bowdring Jr. | Treasurer & Secretary | N/A | 1958 (67 年) |
Ms. Terah Krigsvold | Controller | N/A |
住所: United States, Sarasota. FL, 5582 Broadcast Court - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.invobio.com
Webサイト: https://www.invobio.com